VentriPoint Diagnostics Ltd VPTDF

Primary Symbol: V.VPT

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

<< Previous

Bullboard Posts

Next >>

Post by jopatcloon Nov 14, 2024 3:05pm

83 Views

Post# 36313366

AI-powered platform integrated into GE HealthCare Viewpoint

Interesting Remember & Us2.ai On Ascend website https://ascendcv.com/ Ascend The BEST automation and analysis of the PLANET GEN3EHO CLICK TO LEARN MORE and CLICK ON Integrations Very interesting see on Us2.ai Seamless, flexible integration with heterogeneous AI, imaging and enterprise IT environments enables a best-of breed approach. Examples include: Us2.ai - Benefit from the the industry’s most sophisticated integration of Us2.ai. Us2.ai FDA-approved measurements feed ASE-validated suggested interpretations that can automatically complete the echo report Save time with single-click navigation to the automated measurement source frame

Us2.ai reposted this

Thanks to the team, Assunta Hospital and Hospital Fatimah have officially gone live with Us2.ai's AI-powered platform integrated into GE HealthCare Viewpoint — bringing a new level of diagnostic accuracy and workflow efficiency to their cardiology teams.

With these latest implementations, Malaysia now has nearly 10 hospitals equipped with Us2.ai technology, empowering healthcare professionals to deliver faster, more precise assessments and improving patient outcomes across the board. The impact of AI in transforming healthcare is tangible, and Malaysia is setting the pace for AI adoption in the region.

Congratulations to all the dedicated teams who made this happen! We’re proud of this achievement and can’t wait to see the positive ripple effects on patient care nationwide.

AIinHealthcare Cardiology Ultrasound Echocardiogram AI Echocardiography DigitalHealth MalaysiaLeadingAI Us2ai Vendorneutral HealthTech AIAdoption InnovationInHealthcare